A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma

Chest

Volumn 143, Issue 5, 2013, Pages 1414-1421

  Kravitz, Jared N ^a   Berry, Max W ^b   Schabel, Stephen I ^b   Judson, Marc A ^c  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; PREDNISONE;

ADULT; ANKYLOSING SPONDYLITIS; ARTERY EMBOLISM; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL PNEUMONIA; BLEEDING TENDENCY; BRONCHIECTASIS; CATHETERIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; DRUG INSTILLATION; FEMALE; FORCED VITAL CAPACITY; GRANULOMATOSIS; HEMOPTYSIS; HOSPITAL DISCHARGE; HUMAN; KIDNEY DYSFUNCTION; LUNG ASPERGILLOSIS; LUNG SARCOIDOSIS; MALE; PNEUMOTHORAX; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; THORAX PAIN;

EID: 84877611217     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1784     Document Type: Article

References (44)

1. Rafferty P, Biggs BA, Crompton GK, Grant IW. What happens to patients with pulmonary aspergilloma? Analysis of 23 cases. Thorax. 1983;38(8):579-583. (Pubitemid 13036986)
2. Lee SH, Lee BJ, Jung DY, et al. Clinical manifestations and treatment outcomes of pulmonary aspergilloma. Korean J Intern Med. 2004;19(1):38-42. (Pubitemid 41237487)
3. Research Committee of the British Thoracic and Tuberculosis Association. Aspergilloma and residual tuberculous cavities - the results of a resurvey. Tubercle. 1970;51(3):227-245.
4. Tomee JF, van der Werf TS, Latge JP, Koeter GH, Dubois AE, Kauffman HF. Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma. Am J Respir Crit Care Med. 1995;151(1):199-204.
5. Addrizzo-Harris DJ, Harkin TJ, McGuinness G, Naidich DP, Rom WN. Pulmonary aspergilloma and AIDS. A comparison of HIV-infected and HIV-negative individuals. Chest. 1997;111(3):612-618. (Pubitemid 27132934)
6. Tomlinson JR, Sahn SA. Aspergilloma in sarcoid and tuberculosis. Chest. 1987;92(3):505-508. (Pubitemid 18006615)
7. Kauffman CA. Quandary about treatment of aspergillomas persists. Lancet. 1996;347(9016):1640. (Pubitemid 26177379)
8. Khan MA, Dar AM, Kawoosa NU, et al. Clinical profile and surgical outcome for pulmonary aspergilloma: nine year retrospective observational study in a tertiary care hospital. Int J Surg. 2011;9(3):267-271.
9. Israel HL, Lenchner GS, Atkinson GW. Sarcoidosis and aspergilloma. The role of surgery. Chest. 1982;82(4):430-432. (Pubitemid 12000600)
10. Regnard JF, Icard P, Nicolosi M, et al. Aspergilloma: a series of 89 surgical cases. Ann Thorac Surg. 2000;69(3):898-903.
11. Garvey J, Crastnopol P, Weisz D, Khan F. The surgical treatment of pulmonary aspergillomas. J Thorac Cardiovasc Surg. 1977;74(4):542-547. (Pubitemid 8204263)
12. Kaestel M, Meyer W, Mittelmeier HO, Gebhardt C. Pulmonary aspergilloma - clinical findings and surgical treatment. Thorac Cardiovasc Surg. 1999;47(5):340-345.
13. Massard G, Roeslin N, Wihlm JM, Dumont P, Witz JP, Morand G. Pleuropulmonary aspergilloma: clinical spectrum and results of surgical treatment. Ann Thorac Surg. 1992;54(6):1159-1164. (Pubitemid 23000107)
14. Riscili BP, Wood KL. Noninvasive pulmonary Aspergillus infections. Clin Chest Med. 2009;30(2):315-335.
15. Lejay A, Falcoz PE, Santelmo N, et al. Surgery for aspergilloma: time trend towards improved results? Interact Cardiovasc Thorac Surg. 2011;13(4):392-395.
16. Mossi F, Maroldi R, Battaglia G, Pinotti G, Tassi G. Indicators predictive of success of embolisation: analysis of 88 patients with haemoptysis. Radiol Med (Torino). 2003;105(1-2):48-55. (Pubitemid 36559777)
17. Shin BS, Jeon GS, Lee SA, Park MH. Bronchial artery embolisation for the management of haemoptysis in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2011;15(8):1093-1098.
18. Uflacker R, Kaemmerer A, Neves C, Picon PD. Management of massive hemoptysis by bronchial artery embolization. Radiology. 1983;146(3):627-634. (Pubitemid 13194799)
19. Chun JY, Belli AM. Immediate and long-term outcomes of bronchial and non-bronchial systemic artery embolisation for the management of haemoptysis. Eur Radiol. 2010;20(3):558-565.
20. Rémy J, Arnaud A, Fardou H, Giraud R, Voisin C. Treatment of hemoptysis by embolization of bronchial arteries. Radiology. 1977;122(1):33-37.
21. Hargis JL, Bone RC, Stewart J, Rector N, Hiller FC. Intracavitary amphotereicin B in the treatment of symptomatic pulmonary aspergillomas. Am J Med. 1980;68(3):389-394. (Pubitemid 10130381)
22. Hammerman KJ, Sarosi GA, Tosh FE. Amphotericin B in the treatment of saprophytic forms of pulmonary aspergillosis. Am Rev Respir Dis. 1974;109(1):57-62.
23. Tsubura E; Pulmonary Aspergilloma Study Group. Multi center clinical trial of itraconazole in the treatment of pulmonary aspergilloma [in Japanese]. Kekkaku. 1997;72(10):557-564.
24. Fujita M, Tao Y, Kajiki A, et al. The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma. J Infect Chemother. 2012;18(5):668-674.
25. Campbell JH, Winter JH, Richardson MD, Shankland GS, Banham SW. Treatment of pulmonary aspergilloma with itraconazole. Thorax. 1991;46(11):839-841.
26. De Beule K, De Doncker P, Cauwenbergh G, et al. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses. 1988;31(9):476-485.
27. Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol. 1990;23(3 pt 2):607-614. (Pubitemid 20263688)
28. Lee KS, Kim HT, Kim YH, Choe KO. Treatment of hemoptysis in patients with cavitary aspergilloma of the lung: value of percutaneous instillation of amphotericin B. AJR Am J Roentgenol. 1993;161(4):727-731.
29. Shapiro MJ, Albelda SM, Mayock RL, McLean GK. Severe hemoptysis associated with pulmonary aspergilloma. Percutaneous intracavitary treatment. Chest. 1988;94(6):1225-1231. (Pubitemid 19002784)
30. Rumbak M, Kohler G, Eastrige C, Winer-Muram H, Gavant M. Topical treatment of life threatening haemoptysis from aspergillomas. Thorax. 1996;51(3):253-255. (Pubitemid 26086468)
31. Munk PL, Vellet AD, Rankin RN, Müller NL, Ahmad D. Intracavitary aspergilloma: transthoracic percutaneous injection of amphotericin gelatin solution. Radiology. 1993;188(3):821-823. (Pubitemid 23254609)
32. Giron J, Poey C, Fajadet P, et al. CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases. Eur J Radiol. 1998;28(3):235-242. (Pubitemid 28559202)
33. Jackson M, Flower CD, Shneerson JM. Treatment of symptomatic pulmonary aspergillomas with intracavitary instillation of amphotericin B through an indwelling catheter. Thorax. 1993;48(9):928-930. (Pubitemid 23283389)
34. Nardi A, Brillet PY, Letoumelin P, et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J. 2011;38(6):1368-1373.
35. Freundlich IM, Libshitz HI, Glassman LM, Israel HL. Sarcoidosis. Typical and atypical thoracic manifestations and complications. Clin Radiol. 1970;21(4):376-383.
36. Wollschlager C, Khan F. Aspergillomas complicating sarcoidosis. A prospective study in 100 patients. Chest. 1984;86(4):585-588. (Pubitemid 14011186)
37. Research Committee of the British Thoracic and Tuberculosis Association. Aspergillus in persistent lung cavities after tuberculosis. A report from the Research Committee of the British Tuberculosis Association. Tubercle. 1968;49(1):1-11.
38. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179-187. (Pubitemid 29036522)
39. Klein JS, Fang K, Chang MC. Percutaneous transcatheter treatment of an intracavitary aspergilloma. Cardiovasc Intervent Radiol. 1993;16(5):321-324. (Pubitemid 23275166)
40. Mikami M, Nakamura S, Kawakami M. Pulmonary aspergilloma successfully treated with long-term intermittent inhalation therapy with miconazole. Intern Med. 1993;32(3):247-250. (Pubitemid 23235251)
41. Guleria R, Gupta D, Jindal SK. Treatment of pulmonary aspergilloma by endoscopic intracavitary instillation of ketoconazole. Chest. 1993;103(4):1301-1302. (Pubitemid 23110331)
42. Krakówka P, Traczyk K, Walczak J, Halweg H, Elsner Z, Pawlicka L. Local treatment of aspergilloma of the lung with a paste containing nystatin or amphotericin B. Tubercle. 1970;51(2):184-191.
43. Dakov I. Removal of pulmonary aspergilloma by aspiration drainage [in Bulgarian]. Khirurgiia (Sofiia). 1976;29(5):427-428.
44. Kravitz JN, Steed LL, Judson MA. Intracavitary voriconazole for the treatment of hemoptysis complicating Pseudallescheria angusta pulmonary mycetomas in fibrocystic sarcoidosis. Med Mycol. 2011;49(2):198-201.